Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Aurobindo Pharma USA Inc recalls Cinacalcet Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Products
  • Cinacalcet Tablets
Where it was sold

USA Nationwide

Nationwide

Units affected
3336 bottles
About this recall
Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.